People · Operator

Celine Rossignol

Named in public records as an officer, director or promoter · active 2009–2009 · Pharmaceuticals

1
Companies
1
Filings
$115.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Romark Laboratories, L.C.PharmaceuticalsSeries B$115.9M$365.5M2009
Operator network

Celine Rossignol at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

W. Andrew Krusen, Jr. · 4 companies · 1 sharedW. Andrew Krusen,…Brian S. Schnieders · 2 companies · 1 sharedBrian S. Schniede…Celine S. Rossignol · 2 companies · 1 sharedCeline S. Rossign…Marc S. Ayers · 2 companies · 1 sharedMarc S. AyersW. Seymour Holt · 2 companies · 1 sharedW. Seymour HoltBrian E. Schnieders · 1 companies · 1 sharedBrian E. Schniede…Brian Schnieders · 1 companies · 1 sharedBrian SchniedersCeline E. Rossignol · 1 companies · 1 sharedCeline E. Rossign…Emmet B. Keefe · 1 companies · 1 sharedEmmet B. KeefeJean Francois Rossignol · 1 companies · 1 sharedJean Francois Ros…Jeff B. Crowther · 1 companies · 1 sharedJeff B. CrowtherJeff Crowther · 1 companies · 1 sharedJeff CrowtherKurt Andrew Frahn · 1 companies · 1 sharedKurt Andrew FrahnRomark Laboratories, L.C. · $115.9M raisedRomark Laboratories, …Celine RossignolCR
Celine Rossignol Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Celine Rossignol on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
W. Andrew Krusen, Jr.14
W. Seymour Holt12
Celine S. Rossignol12
Marc S. Ayers12
Brian S. Schnieders12
Kurt Andrew Frahn11
Jeff Crowther11
Jeff B. Crowther11
Brian Schnieders11
Emmet B. Keefe11
Jean Francois Rossignol11
Brian E. Schnieders11
Celine E. Rossignol11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.